Literature DB >> 4349188

[Histocompatibility antigens and trophoblastic tumors].

G Tatra, E Wolf.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4349188     DOI: 10.1007/bf00673139

Source DB:  PubMed          Journal:  Arch Gynakol        ISSN: 0003-9128


× No keyword cloud information.
  14 in total

1.  TROPHOBLASTIC TUMORS; GEOGRAPHICAL VARIATIONS IN INCIDENCE AND POSSIBLE AETIOLOGICAL FACTORS.

Authors:  D LLEWELLYN-JONES
Journal:  J Obstet Gynaecol Br Commonw       Date:  1965-04

2.  Choriocarcinoma. Observations on the etiology.

Authors:  J S SCOTT
Journal:  Am J Obstet Gynecol       Date:  1962-01-15       Impact factor: 8.661

3.  Blood group factors in women with choriocarcinoma as compared with those of their husbands.

Authors:  P J SCHMIDT; R HERTZ
Journal:  Am J Obstet Gynecol       Date:  1961-09       Impact factor: 8.661

4.  Choriocarcinoma and the HL-A2 antigen (MAC).

Authors:  J L Amiel; S Lebovici
Journal:  Rev Eur Etud Clin Biol       Date:  1970-02

5.  ABO blood-groups in trophoblastic neoplasia.

Authors:  K D Bagshawe; G Rawlins; M C Pike; S D Lawler
Journal:  Lancet       Date:  1971-03-20       Impact factor: 79.321

6.  The HL-A system in trophoblastic neoplasia.

Authors:  S D Lawler; P T Klouda; K D Bagshawe
Journal:  Lancet       Date:  1971-10-16       Impact factor: 79.321

7.  [Determination of anti-HL-A-antibodies in cytotoxic pregnancy sera].

Authors:  E Wolf
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1971-08

8.  The prognostic application of HL-A and ABO typing in placental choriocarcinoma.

Authors:  B Mogensen; F Kissmeyer-Nielsen
Journal:  Dan Med Bull       Date:  1969-09

9.  HL-A antigens and choriocarcinoma.

Authors:  E Ivaskova; J Jakoubkova; M Zavadil; V Schneid; P Koldovsky; P Ivany
Journal:  Transplant Proc       Date:  1969-03       Impact factor: 1.066

10.  HL-A antigens and the choriocarcinoma.

Authors:  E Ivasková; J Jakoubková; M Zavadil; V Schneid; P Koldovský; P Iványi
Journal:  Folia Biol (Praha)       Date:  1968       Impact factor: 0.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.